Assyro AI

FDA Orange Book · active-ingredient family

Brompheniramine maleate

Brompheniramine maleate is approved as 2 brand and 16 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DIMETANE · NDA 010799

2

Brand (NDA)

16

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · elixir, injectable, tablet, tablet, extended release

ProductApplicantApplicationTEApproved
DIMETANE×3WYETH CONSNDA 010799Jun 10, 1983
DIMETANE-TENWYETH AYERSTNDA 011418Approved Prior to Jan 1, 1982

Generic (ANDA) products (16)

ProductApplicantApplicationTEApproved
BROMPHENIRAMINE MALEATEPIONEER PHARMSANDA 088604Jul 13, 1984
BROMPHENIRAMINE MALEATEUSL PHARMAANDA 087964Jan 25, 1983
BROMPHENIRAMINE MALEATEALPHARMA US PHARMSANDA 086936Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEKV PHARMANDA 085466Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEPHARM ASSOCANDA 087517Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEWATSON LABSANDA 083821Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEWATSON LABSANDA 083820Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEBARRANDA 084468Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEIVAX SUB TEVA PHARMSANDA 084351Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATENEWTRON PHARMSANDA 086987Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATENEXGEN PHARMA INCANDA 086187Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEPAR PHARMANDA 087009Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEUPSHER SMITH LABSANDA 083215Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEVITARINEANDA 085850Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEWATSON LABSANDA 083123Approved Prior to Jan 1, 1982
BROMPHENIRAMINE MALEATEWATSON LABSANDA 085769Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Brompheniramine maleate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.